Director, Key Opinion Leader Marketing, Rare Disease

About this role

Title: Director, Key Opinion Leader Marketing, Rare Disease Company: Ipsen Biopharmaceuticals Inc.   About Ipsen: Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation.  Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society! For more information, visit us at https://www.ipsen.com/   and follow our latest news on LinkedIn and Instagram .

Job Description: Ipsen’s Rare Disease franchise has been expanding through both organic growth and acquisitions. From a marketing standpoint, there is a critical need for excellence in strategic planning and excellence in execution to clearly define how we will best drive education of appropriate healthcare providers, deliver successful launches, and innovate for patients in complex and competitive therapeutic areas. 

The Director, Key Opinion Leader Marketing, Rare Disease is a strategic leader within the U.S. Rare Liver Marketing team, responsible for defining and advancing the peer-to-peer engagement strategy across the portfolio. This role serves as the architect of Ipsen's external expert engagement ecosystem, shaping how scientific leaders, advocates, and peer influencers are engaged to advance disease-state education, support earlier diagnosis, inform brand strategy, and drive adoption across existing and future portfolio assets. This role requires deep expertise in external expert engagement, peer-to-peer education, and congress strategy, as well as the scientific acumen, executive presence, and cross-functional leadership necessary to influence senior stakeholders and drive portfolio-wide impact.

This role owns the strategic direction and governance of speaker bureau excellence, KOL engagement, peer to peer education, and congress activation across the U.S. rare disease portfolio. This individual ensures a coordinated and highly credible external engagement approach that elevates Ipsen's scientific leadership and commercial impact.

This is not a field or remote role, it's based in our Cambridge, MA HQ.   WHAT - Main Responsibilities Peer Engagement Strategy • Own and evolve the enterprise peer-to-peer engagement strategy across the U.S. Rare Disease portfolio, ensuring alignment with portfolio growth objectives, competitive dynamics, and future launch priorities • Establish portfolio-level KOL, speaker, and advocate engagement frameworks, segmentation approaches, and investment priorities that maximize scientific influence and educational impact • Build a credible, science-driven peer to peer offering aligned to portfolio priorities including tools and resources for TLL team • Prioritize peer-to-peer programs and channels to expand reach and frequency across key stakeholders • Build and manage congress roadmap, capabilities, and continually improve associated processes • Ensure a single, cohesive peer to peer experience aligned to brand strategy and priorities • Shape how peer influence is leveraged across the customer journey to support disease-state awareness, diagnosis acceleration, treatment adoption, and launch readiness

Portfolio Leadership & Governance • Own and continuously evolve the portfolio speaker bureau strategy, governance, and operating model, ensuring alignment to business priorities and maximizing the impact of peer-to-peer engagement investments • Establish governance and oversight for speaker engagement, contracting, fair market value rates, utilization, and HCP transparency practices across the rare disease portfolio. • Define and lead the portfolio congress strategy, including prioritization of investments, scientific engagement plans, sponsorship opportunities, and cross-brand activation designed to maximize organizational impact • Direct the design and execution of integrated congress and peer-to-peer engagement plans that advance disease-state education, strengthen scientific leadership, and support portfolio growth objectives. • Lead strategic partnerships with agencies and external vendors, ensuring delivery of innovative, high-impact engagement programs while optimizing resource allocation and return on investment. • Partner with Medical, PRC, Legal, and Business Ethics to establish governance frameworks and ensure compliant execution of peer engagement activities across the portfolio.

Insights, Measurement & Leadership • Serve as the organization's center of excellence for peer engagement strategy, establishing standards, governance, and best practices across the rare disease portfolio • Define KPIs and measurement to optimize speaker and congress program performance and ROI • Own portfolio speaker bureau and congress budget planning and resource allocation • Ensuring on-time and on-budget delivery of congresses, and sponsorships • Synthesize insights from KOL interactions, congress engagement, speaker bureau activity, and competitive intelligence to inform portfolio strategy, launch planning, and business decision-making • Establish clear governance, decision-making, and prioritization across the team and partners • Drive alignment with Brand, Sales, TLL, Medical, PRC and Business ethics • Influence senior leadership through data-driven recommendations regarding market dynamics, emerging scientific trends, KOL sentiment, and external stakeholder priorities

HOW - Knowledge & Experience Knowledge & Experienc

Similar jobs

• Director, U.S. HCP Marketing Strategy, Rare Hematology — AstraZeneca · MA, Boston
• Associate Director, Commercial Training Rare Disease — Ipsen · Berkeley Heights | Cambridge (US)
• Thought Leader Liaison - Rare Disease (Uplizna) - Michigan — Amgen · Detroit, Michigan, United States
• Director, Thought Leader Liaison, US Psoriasis Launch — Alumis · Remote
• Thought Leader Liaison - UPLIZNA - Rocky Mountains (Rare Disease) — Amgen · Wichita, Kansas, United States
• Associate Director, Patient Marketing — Cogentbiosciences · Waltham, Massachusetts, United States
• Associate Director, Patient Marketing — Blueprintmedicines · Cambridge, MA, United States
• Director, Marketing (Rx and OTC) — Clicktherapeutics · New York, NY